UNITEDHEALTH GROUP INC - 2006 10-K Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2006. UnitedHealth Group is a diversified health and well-being company serving approximately 70 million Americans. The filing includes a comprehensive restatement of financial statements for periods from 1994 through 2005, and the first three quarters of 2006, due to errors in accounting for historic stock option grants (specifically regarding measurement dates and backdating). The company adopted FAS 123R (Share-Based Payment) on January 1, 2006, using the modified retrospective method.
Key business developments in 2006 included the full-year integration of the PacifiCare acquisition (completed Dec 2005) and the launch of the Medicare Part D prescription drug program on January 1, 2006. Significant senior leadership changes occurred, with Stephen J. Hemsley becoming CEO in November 2006.
Key Financial Metrics (2006 vs. 2005 Restated)
| Metric | 2006 (Restated) | 2005 (Restated) | Change |
|---|---|---|---|
| Total Revenues | $71.5 billion | $46.4 billion | +54% |
| Net Earnings | $4.2 billion | $3.1 billion | +35% |
| Diluted EPS | $2.97 | $2.31 | +29% |
| Operating Margin | 9.8% | 10.9% | -1.1 pts |
| Cash Flow from Operations | $6.5 billion | $4.1 billion | +60% |
| Total Debt | $7.5 billion | $7.1 billion | +6% |
| Cash and Investments | $20.6 billion | $15.0 billion | +37% |
Note: 2005 figures are presented on a FAS 123R basis to ensure comparability with 2006.
Material Changes and Drivers
- Revenue Growth: The 54% revenue increase was driven primarily by the PacifiCare acquisition and the new Medicare Part D program (which generated $5.7 billion in revenue). Excluding acquisitions, organic revenue growth was 21%.
- Margin Compression: Operating margins declined from 10.9% to 9.8% due to the lower-margin mix of the new Medicare Part D business and the PacifiCare acquisition.
- Medical Costs: The medical care ratio increased to 81.2% from 80.0%, reflecting the higher cost structure of the new Part D program and PacifiCare.
- Restatement Impact: The restatement resulted in additional stock-based compensation expense. For 2005, the restatement reduced net earnings by approximately $238 million (under APB 25) and $57 million (under FAS 123R) compared to previously reported figures.
Outlook, Risks, and Contingencies
- Stock Option Litigation & Investigations: The company is subject to formal investigations by the SEC, IRS, U.S. Attorney for the Southern District of New York, and the Minnesota Attorney General regarding historic stock option practices. Multiple shareholder derivative and class-action lawsuits are pending.
- Internal Controls: The company identified a material weakness in internal controls over financial reporting as of December 31, 2005, related to stock option administration. Management concluded this weakness was remediated as of December 31, 2006.
- Debt Covenants: The company received a notice of default regarding its 5.8% Senior Unsecured Notes due to delayed filing of quarterly reports. The company filed a declaratory judgment action to contest this. If unsuccessful, it may be required to retire $850 million of debt.
- Future Charges: The company expects to take a charge of approximately $55 million (net of tax) in Q1 2007 related to Section 409A tax costs for certain employee stock options.
- Guidance: The company suspended its stock repurchase program in Q3 2006 pending the completion of the restatement and intends to resume it in 2007.
Investor Verification Checklist
- Restatement Accuracy: Verify the final impact of the stock option restatement on historical earnings and the adequacy of the remediation of internal controls.
- Legal Exposure: Monitor the status of the declaratory judgment action regarding the debt indenture default and the potential for fines or penalties from regulatory investigations.
- Medicare Part D Performance: Assess the profitability and enrollment trends of the Medicare Part D program, which significantly impacts the overall medical care ratio.
- Debt Ratings: Track credit rating actions (currently A/A3 with negative outlooks) and the cost of borrowing given the ongoing legal and governance uncertainties.
- Section 409A Charge: Confirm the timing and magnitude of the anticipated $55 million tax charge in the first quarter of 2007.